Biologic approaches to articular cartilage surgery: future trends.
The treatment of unicompartmental osteoarthritis and focal chondral pathologic conditions in the knee in active aging athletes has captured the interest of patients, clinicians, basic scientists, and medical industry researchers. Most would agree that a biologic solution to treating hyaline cartilage injuries and degeneration would be optimal over prosthetic joint arthroplasty. Articular cartilage resurfacing techniques and biologic surgical methods continue to evolve and have gained more acceptance in orthopedic practice. A consensus exists for the ultimate goal of achieving a more predictable and durable result after surgical tissue repair or regeneration. Numerous promising approaches are now on the horizon and although the final word is far from in, the integration of many of the anticipated advances in molecular medicine, biomedical engineering, polymer chemistry, cell biology, and clinical orthopedics contributes to an exciting and rapidly evolving field. This article reviews the current concepts of the biologic approach to articular cartilage pathologic conditions and discusses future trends and novel technologies.
Sgaglione
Nicholas A
NA
North Shore University Hospital, Department of Orthopaedics, 600 Northern Boulevard, Great Neck, NY 11021, USA. nas@optonline.net
D001178:Arthroplasty / Q000639:trends; D001691:Biological Therapy / Q000639:trends*; D002357:Cartilage Diseases / Q000628:therapy*; D002358:Cartilage, Articular / Q000293:injuries* / Q000503:physiopathology / Q000601:surgery; D019902:Chondrocytes / Q000637:transplantation; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D012038:Regeneration; D023822:Tissue Engineering
D006133:Growth Substances